<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BDB62FBC-921E-49FF-AD56-909ED429E427"><gtr:id>BDB62FBC-921E-49FF-AD56-909ED429E427</gtr:id><gtr:name>Institute of Tropical Medicine</gtr:name><gtr:address><gtr:line1>Nationalestraat 155</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/BD59C3A8-2737-44E2-A3C6-002F8B1BF00F"><gtr:id>BD59C3A8-2737-44E2-A3C6-002F8B1BF00F</gtr:id><gtr:name>London School of Hygiene and Tropical Medicine, Biacore facility</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AB534209-3172-41E0-A85E-143F22107607"><gtr:id>AB534209-3172-41E0-A85E-143F22107607</gtr:id><gtr:name>Harvard School of Public Health</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BDB62FBC-921E-49FF-AD56-909ED429E427"><gtr:id>BDB62FBC-921E-49FF-AD56-909ED429E427</gtr:id><gtr:name>Institute of Tropical Medicine</gtr:name><gtr:address><gtr:line1>Nationalestraat 155</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BD59C3A8-2737-44E2-A3C6-002F8B1BF00F"><gtr:id>BD59C3A8-2737-44E2-A3C6-002F8B1BF00F</gtr:id><gtr:name>London School of Hygiene and Tropical Medicine, Biacore facility</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4392299B-45A0-4B1F-A45B-28B39C51452F"><gtr:id>4392299B-45A0-4B1F-A45B-28B39C51452F</gtr:id><gtr:name>Broad Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AB534209-3172-41E0-A85E-143F22107607"><gtr:id>AB534209-3172-41E0-A85E-143F22107607</gtr:id><gtr:name>Harvard School of Public Health</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/4A787B93-51AB-4034-B034-8A4171ED96A5"><gtr:id>4A787B93-51AB-4034-B034-8A4171ED96A5</gtr:id><gtr:firstName>Brian</gtr:firstName><gtr:otherNames>Mellor</gtr:otherNames><gtr:surname>Greenwood</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8EF0F6C5-99E5-493D-BA36-8ADE005F79A6"><gtr:id>8EF0F6C5-99E5-493D-BA36-8ADE005F79A6</gtr:id><gtr:firstName>Alfred</gtr:firstName><gtr:otherNames>Amambua</gtr:otherNames><gtr:surname>Ngwa</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DF45180A-FF55-4FCA-84FB-B2DB24B7A222"><gtr:id>DF45180A-FF55-4FCA-84FB-B2DB24B7A222</gtr:id><gtr:firstName>Umberto</gtr:firstName><gtr:surname>D'Alessandro</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/F55CB91E-B41C-42AD-BFB5-8D01E07C3E62"><gtr:id>F55CB91E-B41C-42AD-BFB5-8D01E07C3E62</gtr:id><gtr:firstName>Steven</gtr:firstName><gtr:otherNames>William</gtr:otherNames><gtr:surname>Lindsay</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B13A2953-E9EA-44CB-A5D9-75DE763F0FA8"><gtr:id>B13A2953-E9EA-44CB-A5D9-75DE763F0FA8</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:surname>Drakeley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0D717A98-AB54-4E08-9DE5-702056CC113C"><gtr:id>0D717A98-AB54-4E08-9DE5-702056CC113C</gtr:id><gtr:firstName>Martin James</gtr:firstName><gtr:surname>Donnelly</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CDD0F60B-FB27-4CAF-8F9C-AF2F651A372A"><gtr:id>CDD0F60B-FB27-4CAF-8F9C-AF2F651A372A</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Conway</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CF99A386-990A-49B0-9577-00E756482588"><gtr:id>CF99A386-990A-49B0-9577-00E756482588</gtr:id><gtr:firstName>Koen</gtr:firstName><gtr:surname>Peeters</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MC_EX_MR%2FJ002364%2F1"><gtr:id>0571BB56-4312-4F51-A8B6-6CE5571C8AD7</gtr:id><gtr:title>Defining malaria transmission dynamics in the Gambia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MC_EX_MR/J002364/1</gtr:grantReference><gtr:abstractText>Though still affecting an important proportion of the world population, malaria has declined substantially in the last few years, thanks also to the scale up of interventions such as bed nets treated with insecticide. Such decrease has been observed also in sub-Saharan African countries. It is now recognised that the knowledge needed to support any elimination effort is limited and that a new attempt in this direction should be supported by a strong research component. This research program aims at understanding the dynamics of malaria transmission and the reasons why this can substantially differ within few kilometres. The populations of 12 villages will be intensively followed up for 3 transmission seasons to understand who the malaria carriers are and how the infection spreads across the populations. Information on the vector population, including the presence of insecticide resistance, and on the human behaviour will be collected to partly explain the likely differences between the study villages. The results of this research program will be important for any sub-Saharan African country willing to go towards elimination of malaria. They will be disseminated through international and regional conferences, and by international peer-reviewed publications and communications.</gtr:abstractText><gtr:technicalSummary>Malaria elimination came recently back onto the global public health agenda when a substantial malaria decrease was observed worldwide, including in sub-Saharan Africa. In The Gambia, malaria has markedly decreased over the last few years, a result attributed to the interventions' scale-up. Transmission will further decrease but the impact will not be uniform and pockets of transmission will remain. The objectives of this proposed research program is to understand the dynamics of malaria transmission in a context of high coverage of standard control interventions.
Six areas with substantial transmission have been identified and 2 villages per area (lowest and highest malaria prevalence), selected and intensively followed up (monthly bleeds and passive case detection) for 3 transmission seasons. Blood samples will be screened for infection and then those positive genotyped. The human reservoir will be defined by membrane feeding assays and by detecting gametocytes with molecular methods. For the vector, target-site, metabolic and behavioural resistance will be determined. For human behavioural factors, a mixed methods study design (qualitative and quantitative) will be used. Modelling will synthesize information, quantify uncertainty and generate new hypotheses. 
The results of this research program will be important for any sub-Saharan African country willing to go towards elimination of malaria. They will be disseminated through conferences, and by international publications and communications.</gtr:technicalSummary><gtr:potentialImpactText>The proposed research program has the potential of having a large impact on the way malaria control and elimination are tackled in sub-Saharan Africa. The component on the dynamics of transmission will provide knowledge on the residual foci of malaria infection in a context of high coverage of control interventions. It will identify some or most of the determinants (related to the vector and to human behaviour) maintaining these foci. In addition, it will provide information on whether it is possible and how to identify asymptomatic carriers and individuals infectious to mosquitoes. Therefore, the primary beneficiary from the research will be the Gambian National Malaria Control Program (NMCP) and the Gambians still living in areas with ongoing transmission. Results of this program will help the NMCP to better target residual foci of transmission and to decrease the risk of malaria transmission for the local populations. Considering that the situation in The Gambia is similar to other countries in the West African region, the corresponding NMCP will also be able to use the information produced to better target their efforts. This research program will also provide valuable information to international agencies, e.g. World Health Organization, involved in the formulation of guidelines related to malaria elimination or in the funding of elimination efforts. 

The component on tools will result in a simple, easy-to-use, molecular diagnostic test to identify asymptomatic parasite carriers. The NMCPs (in African and in other endemic continents) and any other organization involved in malaria control/elimination activities will benefit enormously from the availability of such test(s) as they will be able to identify and immediately treat asymptomatic carriers. This should reduce the human reservoir and reduce or eliminate transmission. Though asymptomatic carriers are not ill, the availability of the test will allow better targeting them in campaigns aiming at treating all infected individuals. By decreasing the risk of unnecessarily treating uninfected people, it will reduce the occurrence of adverse drug reactions. Commercial private sector could use the results for the mass production of the test. Similarly, the proteomics study will generate knowledge that could be used by the commercial private sector to develop a new diagnostic test.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-01-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>0</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard School of Public Health</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Program grant</gtr:description><gtr:id>DAA8DC8F-9ACE-4E23-8557-BB2B8B149508</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Durham University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Biological and Biomedical Sciences</gtr:department><gtr:description>Program grant</gtr:description><gtr:id>846A9849-9BEF-465E-B212-98B7229A5701</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Vector Biology</gtr:department><gtr:description>Program grant</gtr:description><gtr:id>2FCBF891-7EF1-47D9-BEA1-621B615E80FF</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>University Medical Center Nijmegen</gtr:department><gtr:description>Program grant</gtr:description><gtr:id>03FD4C3C-72D8-4FE3-B072-4E3E08E57B0E</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Tropical Medicine Antwerp</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Program grant</gtr:description><gtr:id>6E6F9180-E559-4D74-9925-EB4DA7174F8F</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Broad Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Program grant</gtr:description><gtr:id>8D5A5DA1-33A3-4098-942D-91AE7D492A5F</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Program grant</gtr:description><gtr:id>12BC2510-DD8B-473F-8B6E-9B7137735FF5</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine, Biacore facility</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Tropical Epidemiology Group / Faculty of Infectious Diseases</gtr:department><gtr:description>Program grant</gtr:description><gtr:id>F7A6955A-FF63-4BAA-B576-63F67165CD26</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>John Hopkins Malaria Research Institute (JHMRI)</gtr:department><gtr:description>Program grant</gtr:description><gtr:id>1CA321DD-29F9-4300-861B-40464F0B1FE7</gtr:id><gtr:impact>None so far, the program has started a few months ago.</gtr:impact><gtr:partnerContribution>Each partner will contribute to a specific part of the program grant</gtr:partnerContribution><gtr:piContribution>The partnership is built around the program grant I have recently secured.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F786F9CF-3AED-4244-87F3-142D83C37182"><gtr:id>F786F9CF-3AED-4244-87F3-142D83C37182</gtr:id><gtr:title>The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/384a8f9f99798f26b75170d533fc0838"><gtr:id>384a8f9f99798f26b75170d533fc0838</gtr:id><gtr:otherNames>Okebe J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6BE2172D-5150-4D19-AB37-30C2C72A29D6"><gtr:id>6BE2172D-5150-4D19-AB37-30C2C72A29D6</gtr:id><gtr:title>'Some anti-malarials are too strong for your body, they will harm you.' Socio-cultural factors influencing pregnant women's adherence to anti-malarial treatment in rural Gambia.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bb67207dbe4947d23f52cc77690a1755"><gtr:id>bb67207dbe4947d23f52cc77690a1755</gtr:id><gtr:otherNames>Jaiteh F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B7EF33C-FCE6-41C6-890B-77239821F2EF"><gtr:id>0B7EF33C-FCE6-41C6-890B-77239821F2EF</gtr:id><gtr:title>Factors Associated with Non-Participation and Non-Adherence in Directly Observed Mass Drug Administration for Malaria in The Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ce8d35873897f16334ccf08e3fc57491"><gtr:id>ce8d35873897f16334ccf08e3fc57491</gtr:id><gtr:otherNames>Dierickx S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/65F2A204-1CA3-4F9D-BC3C-963A0625BF4B"><gtr:id>65F2A204-1CA3-4F9D-BC3C-963A0625BF4B</gtr:id><gtr:title>School-based countrywide seroprevalence survey reveals spatial heterogeneity in malaria transmission in the Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/384a8f9f99798f26b75170d533fc0838"><gtr:id>384a8f9f99798f26b75170d533fc0838</gtr:id><gtr:otherNames>Okebe J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/86E7E8F9-459E-4C05-99CC-A2393717804A"><gtr:id>86E7E8F9-459E-4C05-99CC-A2393717804A</gtr:id><gtr:title>On-going malaria transmission in The Gambia despite high coverage of control interventions: a nationwide cross-sectional survey.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/25af9d9a53f7482d7e757e5a352bcaf3"><gtr:id>25af9d9a53f7482d7e757e5a352bcaf3</gtr:id><gtr:otherNames>Mwesigwa J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F484ED71-00E7-4EFB-A70F-5A523E87D37A"><gtr:id>F484ED71-00E7-4EFB-A70F-5A523E87D37A</gtr:id><gtr:title>Foul wind, spirits and witchcraft: illness conceptions and health-seeking behaviour for malaria in the Gambia.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fc4b762bf84c35cd96f6d728d1c74749"><gtr:id>fc4b762bf84c35cd96f6d728d1c74749</gtr:id><gtr:otherNames>O'Neill S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FA2A1052-633C-408F-B342-868E9BA2714E"><gtr:id>FA2A1052-633C-408F-B342-868E9BA2714E</gtr:id><gtr:title>The Importance of Blood Is Infinite: Conceptions of Blood as Life Force, Rumours and Fear of Trial Participation in a Fulani Village in Rural Gambia.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fc4b762bf84c35cd96f6d728d1c74749"><gtr:id>fc4b762bf84c35cd96f6d728d1c74749</gtr:id><gtr:otherNames>O'Neill S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5EA20173-9ACE-44AD-9D08-E046504B6142"><gtr:id>5EA20173-9ACE-44AD-9D08-E046504B6142</gtr:id><gtr:title>Serology describes a profile of declining malaria transmission in Farafenni, The Gambia.</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a6755bcf9927bd4a9fd308ef1f5cd7e0"><gtr:id>a6755bcf9927bd4a9fd308ef1f5cd7e0</gtr:id><gtr:otherNames>van den Hoogen LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/511431D3-9682-4D7D-9FE0-1C49494AD40E"><gtr:id>511431D3-9682-4D7D-9FE0-1C49494AD40E</gtr:id><gtr:title>Does insecticide resistance contribute to heterogeneities in malaria transmission in The Gambia?</gtr:title><gtr:parentPublicationTitle>Malaria journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f6072e6d3173efb4fb714acfe764a0bc"><gtr:id>f6072e6d3173efb4fb714acfe764a0bc</gtr:id><gtr:otherNames>Opondo KO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1475-2875</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_EX_MR/J002364/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>